Investment banks compete for biotech business

11/13/2012 | Xconomy

JP Morgan, Bank of America/Merrill Lynch and Goldman Sachs are among the investment banks underwriting biotech companies this year, Securities and Exchange Commission filings show. Other investors include Needham & Co., BMO Capital Markets, Stifel Nicolaus and Oppenheimer. The financing of Regulus Therapeutics, which does not have a drug in clinical trials, shows that Wall Street may be willing to take more risks on biotech, Luke Timmerman writes.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL